BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20920750)

  • 1. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility.
    Hitchins MP
    Adv Genet; 2010; 70():201-43. PubMed ID: 20920750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms in the pathogenesis of Lynch syndrome.
    Peltomäki P
    Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.
    Crépin M; Dieu MC; Lejeune S; Escande F; Boidin D; Porchet N; Morin G; Manouvrier S; Mathieu M; Buisine MP
    Hum Mutat; 2012 Jan; 33(1):180-8. PubMed ID: 21953887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.
    Goel A; Nguyen TP; Leung HC; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok CT; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP
    Int J Cancer; 2011 Feb; 128(4):869-78. PubMed ID: 20473912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer.
    Hitchins MP; Ward RL
    J Med Genet; 2009 Dec; 46(12):793-802. PubMed ID: 19564652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
    Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
    Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort.
    Hitchins MP; Owens SE; Kwok CT; Godsmark G; Algar UF; Ramesar RS
    Clin Genet; 2011 Nov; 80(5):428-34. PubMed ID: 21375527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
    Alemayehu A; Sebova K; Fridrichova I
    Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Germ-line epimutations and human cancer].
    Wu PY; Fan YM; Wang YP
    Ai Zheng; 2009 Dec; 28(12):1236-42. PubMed ID: 19958615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
    Hitchins MP
    Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable germline epimutation is not the same as transgenerational epigenetic inheritance.
    Chong S; Youngson NA; Whitelaw E
    Nat Genet; 2007 May; 39(5):574-5; author reply 575-6. PubMed ID: 17460682
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges in the identification of MSH6-associated colorectal cancer: rectal location, less typical histology, and a subset with retained mismatch repair function.
    Klarskov L; Holck S; Bernstein I; Okkels H; Rambech E; Baldetorp B; Nilbert M
    Am J Surg Pathol; 2011 Sep; 35(9):1391-9. PubMed ID: 21836479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndrome.
    Kwok CT; Ward RL; Hawkins NJ; Hitchins MP
    Fam Cancer; 2010 Sep; 9(3):345-56. PubMed ID: 20063070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.
    Castillejo A; Hernández-Illán E; Rodriguez-Soler M; Pérez-Carbonell L; Egoavil C; Barberá VM; Castillejo MI; Guarinos C; Martínez-de-Dueñas E; Juan MJ; Sánchez-Heras AB; García-Casado Z; Ruiz-Ponte C; Brea-Fernández A; Juárez M; Bujanda L; Clofent J; Llor X; Andreu M; Castells A; Carracedo A; Alenda C; Payá A; Jover R; Soto JL
    J Med Genet; 2015 Jul; 52(7):498-502. PubMed ID: 25908759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.
    Crucianelli F; Tricarico R; Turchetti D; Gorelli G; Gensini F; Sestini R; Giunti L; Pedroni M; Ponz de Leon M; Civitelli S; Genuardi M
    Epigenetics; 2014 Oct; 9(10):1431-8. PubMed ID: 25437057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.
    Kwok CT; Vogelaar IP; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Rapkins RW; Ward RL; Chun N; Ford JM; Ladabaum U; McKinnon WC; Greenblatt MS; Hitchins MP
    Eur J Hum Genet; 2014 May; 22(5):617-24. PubMed ID: 24084575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.